Production (Stage)
Tevogen Bio Holdings Inc.
TVGN
$1.31
$0.086.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.36M | -13.73M | -7.92M | -5.94M | -18.46M |
| Total Depreciation and Amortization | 410.60K | 403.50K | 400.90K | 392.80K | 385.50K |
| Total Amortization of Deferred Charges | -800.00K | 0.00 | 800.00K | 800.00K | 800.00K |
| Total Other Non-Cash Items | 23.48M | 1.33M | -4.89M | -6.44M | 8.36M |
| Change in Net Operating Assets | -873.10K | -5.50K | 675.40K | 2.26M | 755.20K |
| Cash from Operations | -13.14M | -12.00M | -10.93M | -8.92M | -8.16M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | 3.00M | 1.00M | 1.35M | 1.50M | 1.50M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.00M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 8.80M | 11.00M | 9.00M | 5.00M | 2.20M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 229.30K | 301.60K | 101.60K | 101.60K |
| Cash from Financing | 13.80M | 12.23M | 10.65M | 6.60M | 3.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 657.00K | 230.60K | -275.90K | -2.32M | -4.36M |